Table 1.

Details of AD specimens from cohort 2

Specimen no.	BBID no.	Autopsy no.	Age	Sex	PMI (h)	Braak stage	Neuropath Dx
1	1094	AU-16–693	100	Male	3		Control
2	915	90-A-110	81	Male	14		Control
3	1432	AU-14–1918	83	Female	21		Control
4	100	04-AA-158	87	Female	9		Control
5	508	06-AA-02	95	Female	18	2 stage II	Low-likelihood AD
6	1495	03-AA-39	89	Male	8	2 stage II	Low-likelihood AD
7	394	05-AA-196	90	Male	3	2 stage II	Intermediate-likelihood AD
8	462	10-AA-86	86	Male	21	2 stage II	Intermediate-likelihood AD
9	1181	10-AA-148	65	Female	4	2 stage II	Intermediate-likelihood AD
10	1465	10-AA-34	94	Female	9	3 stage III	Intermediate-likelihood AD
11	958	05-AA-027	82	Female	6	3 stage III	Intermediate-likelihood AD
12	1061	12-AA-172	83	Male	13	3 stage III	Intermediate-likelihood AD
13	1337	10-AA-119	89	Female	17	4 stage IV	Intermediate-likelihood AD
14	206	HI93–20432	77	Male	2	4 stage IV	Intermediate-likelihood AD
15	683	01-AA-18	68	Female	8	4 stage IV	High-likelihood AD
16	234	07-AA-50	65	Male	4	5 stage V	High-likelihood AD
17	659	10-AA-168	79	Female	Not recorded	5 stage V	High-likelihood AD
18	940	02-AA-234	91	Male	7	5 stage V	High-likelihood AD
19	1412	05-AA-171	62	Female	Not recorded	6 stage VI	High-likelihood AD
20	593	97-AA-453	65	Male	18	6 stage VI	High-likelihood AD
21	1228	99-AA-264	72	Female	9	6 stage VI	High-likelihood AD
22	352	96-AA-461	86	Female	8	6 stage VI	High-likelihood AD